Sign In

Communications of the ACM

ACM News

First Crispr Clinical Trial Gets Green Light from ­S Panel


View as: Print Mobile App Share: Send by email Share on reddit Share on StumbleUpon Share on Hacker News Share on Tweeter Share on Facebook
Human T cells (blue), cancer cells (pink)

Human T cells (blue) will soon be modified using the CRISPR technique in a clinical trial to attack cancer cells (pink).

Credit: Steve Gschmeissner/SPL

CRISPR, the genome-editing technology that has taken biomedical science by storm, is finally nearing human trials.

From Nature
View Full Article

 


 

No entries found